Loading...
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrogation for the presence of minimal/measurable residual disease (MRD) by molecular genetic and/or flow cytometric techniques. Although ad...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225688/ https://ncbi.nlm.nih.gov/pubmed/32232484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004770 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|